BLISS GVS PHARMA
|
BLISS GVS PHARMA Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹126 Cr | ₹146 Cr | ₹106 Cr | ₹128 Cr | ₹104 Cr |
| Adjustment | ₹68 Cr | ₹38 Cr | ₹58 Cr | ₹-32 Cr | ₹46 Cr |
| Changes In working Capital | ₹-51 Cr | ₹-47 Cr | ₹-85 Cr | ₹73 Cr | ₹-58 Cr |
| Cash Flow after changes in Working Capital | ₹143 Cr | ₹138 Cr | ₹79 Cr | ₹169 Cr | ₹93 Cr |
| Cash Flow from Operating Activities | ₹106 Cr | ₹103 Cr | ₹34 Cr | ₹135 Cr | ₹64 Cr |
| Cash Flow from Investing Activities | ₹-75 Cr | ₹-83 Cr | ₹-7.75 Cr | ₹-93 Cr | ₹-47 Cr |
| Cash Flow from Financing Activities | ₹-30 Cr | ₹-21 Cr | ₹-25 Cr | ₹-24 Cr | ₹-21 Cr |
| Net Cash Inflow / Outflow | ₹0.13 Cr | ₹-1.27 Cr | ₹1.62 Cr | ₹19 Cr | ₹-3.82 Cr |
| Opening Cash & Cash Equivalents | ₹24 Cr | ₹25 Cr | ₹22 Cr | ₹13 Cr | ₹15 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
| Effect of Foreign Exchange Fluctuations | ₹0.10 Cr | ₹-0.15 Cr | ₹1.40 Cr | ₹-9.92 Cr | ₹1.61 Cr |
| Closing Cash & Cash Equivalent | ₹24 Cr | ₹24 Cr | ₹25 Cr | ₹22 Cr | ₹13 Cr |
Compare Cashflow Statement of peers of BLISS GVS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BLISS GVS PHARMA | ₹2,736.5 Cr | 9.1% | 26.5% | 101.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹397,018.0 Cr | -2.3% | -8.5% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,454.0 Cr | 5.3% | -3.4% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,702.0 Cr | 3.7% | -4.9% | 26% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,830.0 Cr | 1.2% | -4.2% | 5.3% | Stock Analytics | |
| CIPLA | ₹99,325.0 Cr | 2.4% | -7.2% | -18.1% | Stock Analytics | |
BLISS GVS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLISS GVS PHARMA | 9.1% |
26.5% |
101.5% |
| SENSEX | 5.8% |
-1.7% |
1.2% |
You may also like the below Video Courses